Melanotan II: 5 Serious Side Effects And Complications
Unlicensed synthetic hormone for tanning with serious health risks including skin cancer, renal damage, and more.
Melanotan II is an unlicensed and largely untested synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) that induces pigmentation (tanning) of human skin.
What is Melanotan II?
Melanotan II (MT-II) is a cyclic lactam analogue of α-MSH, a peptide hormone naturally produced in the pituitary gland. It non-selectively activates melanocortin receptors (MC1R through MC5R), primarily stimulating MC1R on melanocytes to increase eumelanin production, resulting in skin darkening without UV exposure. Developed in the 1990s at the University of Arizona for potential photoprotection in erythropoietic protoporphyria, it remains unapproved for any medical use worldwide due to safety concerns.
Unlike Melanotan I (afamelanotide, approved in some countries for specific rare conditions), Melanotan II has broader receptor affinity, crossing the blood-brain barrier and affecting sexual function, appetite, and other systems. It is illegally marketed online as a ‘tanning injection,’ nasal spray, or drops, often targeting those seeking a rapid tan.
Who gets Melanotan II?
Primarily young adults, especially fair-skinned individuals desiring a tan without sun exposure. Usage has surged via social media and online forums, with health authorities noting increased listings targeting younger demographics. Reports indicate widespread illicit use in the US, UK, Australia, and Europe, despite bans.
What causes Melanotan II reaction?
Melanotan II mimics melanocortin peptides, natural hormones regulating pigmentation, sexual arousal, energy balance, immunity, inflammation, and cardiovascular function. Binding to MC1R boosts eumelanin synthesis in melanocytes, darkening skin, hair, and eyes. MC4R activation in the brain suppresses appetite and induces erections; MC3R/MC5R influence other effects like nausea.
Administered subcutaneously (most common), intranasally, or orally, it peaks in effect within hours, with tanning building over days to weeks at doses of 0.25–1 mg daily.
What are the clinical features of Melanotan II use?
- Skin darkening: Uniform tanning, especially face, arms, freckles, moles; reversible over months.
- Spontaneous erections: Frequent, prolonged in men (priapism risk).
- Gastrointestinal: Nausea, vomiting, cramps, appetite loss, yawning.
- Neurological: Flushing, fatigue, dizziness, anxiety, tremors.
- Dermatological risks: New/changing moles, potential melanoma.
How is the diagnosis of Melanotan II use made?
Diagnosis relies on history of use (often concealed) and clinical signs like unnatural tan disproportionate to sun exposure, erections, nausea. No routine blood test exists; LC-MS can detect it but not standard. Differential includes Addison disease or other melanocortin disorders.
What is the treatment for reactions to Melanotan II?
Discontinue immediately. Symptomatic: antiemetics for nausea, PDE5 inhibitors or aspiration for priapism, supportive care. Monitor moles/skin cancer; renal function if infarction suspected. No antidote; long-term follow-up essential.
What are the complications of Melanotan II?
Serious risks include:
- Skin cancer: New moles, atypical changes, melanoma links.
- Renal infarction: Thrombotic occlusion causing kidney damage; case reports show 50% renal loss.
- Cardiovascular: Stroke, hypertension.
- Infection: From unsterile injections (HIV, hepatitis).
- Other: Rhabdomyolysis, anaphylaxis, vision loss.
| Category | Common (Mild-Moderate) | Severe (Potentially Life-Threatening) |
|---|---|---|
| Gastrointestinal | Nausea, cramps, appetite loss | Anaphylaxis |
| Skin | Darkening, flushing | Melanoma, new moles |
| Renal | – | Infraction, failure |
| Sexual | Spontaneous erections | Priapism |
| Neurological | Dizziness, yawning | Stroke, tremors |
Prevention of Melanotan II-related harm
Avoid entirely. Health agencies (FDA, MHRA, TGA, HPRA) warn against use due to unknown purity, dosing, and long-term effects. Seek medical alternatives like sunless tanners or approved phototherapies. Report adverse events.
Investigations to order
- Skin exam/biopsy for moles.
- Renal function (creatinine, eGFR), urinalysis, CT if infarction suspected.
- LFTs, CBC for systemic effects.
- STI screen if injection-related.
Alternative tanning methods
- DHA-based sunless tanners (safe, topical).
- Spray tans (professional).
- UV-free self-tanners.
- Sunscreen + gradual sun for natural tan.
Frequently Asked Questions
Q: Is Melanotan II legal?
A: No, unlicensed and illegal for sale/use in US, UK, EU, Australia.
Q: Does Melanotan II cause cancer?
A: Linked to moles/melanoma; stimulates melanocytes abnormally.
Q: How long does tanning last?
A: Weeks to months; fades without maintenance.
Q: Can women use it safely?
A: No; same risks, plus unknown pregnancy effects—avoid.
Q: What’s the difference from Melanotan I?
A: II has broader effects/shorter duration, more side effects.
Regulatory Warnings
HPRA (Ireland): Stop use; report effects. TGA (Australia): Serious risks from injectables/nasal sprays. FDA/others: Unapproved, dangerous.
Melanotan II exemplifies risks of unregulated peptides. Tanning benefits do not outweigh dangers; prioritize skin health.
References
- Reminder of serious health risks with Melanotan 2 self-tan products — Health Products Regulatory Authority (HPRA). 2023-06-14. https://www.hpra.ie/safety-information/safety-notices/article/reminder-of-serious-health-risks-with-melanotan-2-self-tan-products
- Melanotan II: a possible cause of renal infarction — Peters B et al. BMC Nephrol. 2020-04-06. https://pmc.ncbi.nlm.nih.gov/articles/PMC7148395/
- Melanotan: Uses, Side Effects, Precautions, and More — WebMD. Accessed 2026. https://www.webmd.com/vitamins/ai/ingredientmono-884/melanotan
- Tanning Injections: Risks, Side Effects, and Precautions — Healthline. 2025. https://www.healthline.com/health/tanning-injections
- Melanotan II — DermNet NZ. Accessed 2026. https://dermnetnz.org/topics/melanotan-ii
- Don’t risk using tanning products containing melanotan — Therapeutic Goods Administration (TGA). Accessed 2026. https://www.tga.gov.au/news/blog/dont-risk-using-tanning-products-containing-melanotan
Similar Articles
Read full bio of medha deb
